In PD, Alberio and colleagues identified two proteins differentially expressed in T lymphocytes (ß-fibrinogen and transaldolase, [52]) and nine different proteins with differential expression in the plasma [52, 54] of PD patients as potential biomarkers for the disease duration and severity. This evidence concerns the gene TALDO1 and Parkinson disease.